Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register.

Source:http://linkedlifedata.com/resource/pubmed/id/16868999

Download in:

View as

General Info

PMID
16868999